{"transactions":[{"id":1373109,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":86252,"kind":"organization","name":"Boxer Capital Management, LLC","position":1,"cik":"0002018299","reported_name":"Boxer Capital Management, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-11-08T02:30:23.000Z","date":"2024-11-06","kind":"sale","planned":false,"acquired":false,"shares":3080000,"price":3.14,"value":9671200.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.3955, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held indirectly by Boxer Capital Management, LLC (\"BCM\") as the investment manager of an account holding such securities. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Mr. Davis is the Managing Member of BCM and has voting and dispositive power over securities beneficially owned by BCM, but disclaims beneficial ownership of these securities except to the extent of his pecuniary interest, if any."}],"balance_after":3610642,"source":{"system":"sec-edgar","filing":"0000895345-24-000548","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2018299/000089534524000548/form4.xml","form_type":"4"}},{"id":1380746,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":86252,"kind":"organization","name":"Boxer Capital Management, LLC","position":1,"cik":"0002018299","reported_name":"Boxer Capital Management, LLC","relationship":{"other":true,"other_text":"See remarks."}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks."}}],"security":"Common Stock","published_at":"2024-10-28T10:59:22.000Z","date":"2024-10-25","kind":"sale","planned":false,"acquired":false,"shares":633000,"price":6.87,"value":4348710.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.8500 to $6.8700, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are held indirectly by Boxer Capital Management, LLC (\"BCM\") as the investment manager of an account holding such securities. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Mr. Davis is the Managing Member of BCM and has voting and dispositive power over securities beneficially owned by BCM, but disclaims beneficial ownership of these securities except to the extent of his pecuniary interest, if any."}],"balance_after":6690642,"source":{"system":"sec-edgar","filing":"0000895345-24-000485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2018299/000089534524000485/form4.xml","form_type":"4"}},{"id":1382425,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":86252,"kind":"organization","name":"Boxer Capital Management, LLC","position":1,"cik":"0002018299","reported_name":"Boxer Capital Management, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-10-24T01:31:42.000Z","date":"2024-10-22","kind":"sale","planned":false,"acquired":false,"shares":250000,"price":6.78,"value":1695000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.7100 to $6.9050, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are held indirectly by Boxer Capital Management, LLC (\"BCM\") as the investment manager of an account holding such securities. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Mr. Davis is the Managing Member of BCM and has voting and dispositive power over securities beneficially owned by BCM, but disclaims beneficial ownership of these securities except to the extent of his pecuniary interest, if any."}],"balance_after":7323642,"source":{"system":"sec-edgar","filing":"0000895345-24-000470","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2018299/000089534524000470/form4.xml","form_type":"4"}},{"id":1382424,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":86252,"kind":"organization","name":"Boxer Capital Management, LLC","position":1,"cik":"0002018299","reported_name":"Boxer Capital Management, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-10-24T01:31:42.000Z","date":"2024-10-21","kind":"sale","planned":false,"acquired":false,"shares":625000,"price":7.05,"value":4406250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0018 to $7.2372, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These securities are held indirectly by Boxer Capital Management, LLC (\"BCM\") as the investment manager of an account holding such securities. BCM disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Mr. Davis is the Managing Member of BCM and has voting and dispositive power over securities beneficially owned by BCM, but disclaims beneficial ownership of these securities except to the extent of his pecuniary interest, if any."}],"balance_after":7573642,"source":{"system":"sec-edgar","filing":"0000895345-24-000470","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2018299/000089534524000470/form4.xml","form_type":"4"}},{"id":1414076,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks."}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-06T01:01:38.000Z","date":"2024-09-03","kind":"other","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option, which was granted as compensation for consulting services, shall vest and become exercisable in 2 substantially equal installments, with 32,500 shares vesting as of 12/03/2024 and 32,500 shares vesting as of 03/03/2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, which was granted as compensation for consulting services, shall vest and become exercisable in 2 substantially equal installments, with 32,500 shares vesting as of 12/03/2024 and 32,500 shares vesting as of 03/03/2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":65000,"derivative":{"exercise_price":10.93,"expiration_date":"2034-09-03","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000895345-24-000369","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000369/form4.xml","form_type":"4"}},{"id":1463261,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-07-03T00:56:42.000Z","date":"2024-07-02","kind":"sale","planned":false,"acquired":false,"shares":95000,"price":8.68,"value":824600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 to $9.05, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":108793,"source":{"system":"sec-edgar","filing":"0000895345-24-000245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000245/form4.xml","form_type":"4"}},{"id":1463260,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-07-03T00:56:42.000Z","date":"2024-07-01","kind":"sale","planned":false,"acquired":false,"shares":110731,"price":8.87,"value":982183.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.75 to $9.00, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":203793,"source":{"system":"sec-edgar","filing":"0000895345-24-000245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000245/form4.xml","form_type":"4"}},{"id":1463259,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-07-03T00:56:42.000Z","date":"2024-06-28","kind":"sale","planned":false,"acquired":false,"shares":29000,"price":8.57,"value":248530.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.48 to $8.68, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":314524,"source":{"system":"sec-edgar","filing":"0000895345-24-000245","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000245/form4.xml","form_type":"4"}},{"id":1480821,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T20:00:09.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":24200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24200,"derivative":{"exercise_price":16.32,"exercise_date":"2025-06-11","expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":24200},"source":{"system":"sec-edgar","filing":"0000950170-24-073255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000095017024073255/ownership.xml","form_type":"4"}},{"id":1487045,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-06-08T01:14:32.000Z","date":"2024-06-07","kind":"sale","planned":false,"acquired":false,"shares":77000,"price":6.88,"value":529760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.84 to $7.03, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":343524,"source":{"system":"sec-edgar","filing":"0000895345-24-000225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000225/form4.xml","form_type":"4"}},{"id":1487044,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-06-08T01:14:32.000Z","date":"2024-06-06","kind":"sale","planned":false,"acquired":false,"shares":63000,"price":7.24,"value":456120.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":420524,"source":{"system":"sec-edgar","filing":"0000895345-24-000225","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000225/form4.xml","form_type":"4"}},{"id":1518051,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":4,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-14T21:32:26.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":1142857,"price":17.5,"value":19999997.5,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":2946915,"source":{"system":"sec-edgar","filing":"0000895345-24-000172","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000172/form4.xml","form_type":"4"}},{"id":1528528,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-05-04T01:34:33.000Z","date":"2024-05-03","kind":"sale","planned":false,"acquired":false,"shares":60000,"price":7.61,"value":456600.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.56 to $7.81, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":483524,"source":{"system":"sec-edgar","filing":"0000895345-24-000151","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000151/form4.xml","form_type":"4"}},{"id":1528527,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-05-04T01:34:33.000Z","date":"2024-05-02","kind":"sale","planned":false,"acquired":false,"shares":75000,"price":7.56,"value":567000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.59, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":543524,"source":{"system":"sec-edgar","filing":"0000895345-24-000151","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000151/form4.xml","form_type":"4"}},{"id":1528526,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-05-04T01:34:33.000Z","date":"2024-05-01","kind":"sale","planned":false,"acquired":false,"shares":75000,"price":7.43,"value":557250.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.39 to $7.79, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":618524,"source":{"system":"sec-edgar","filing":"0000895345-24-000151","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089534524000151/form4.xml","form_type":"4"}},{"id":1654018,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See Remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See Remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See Remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See Remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Warrant (right to purchase)","published_at":"2024-02-08T17:09:52.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":705280,"price":13.009,"value":9174987.52,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Warrants are exercisable immediately (subject to any applicable beneficial ownership limitation) and do not have an expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These Warrants are exercisable immediately (subject to any applicable beneficial ownership limitation) and do not have an expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. (\"Boxer Management\") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":705280,"derivative":{"exercise_price":0.001,"underlying":"Common Stock","underlying_shares":705280},"source":{"system":"sec-edgar","filing":"0000895345-24-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000035/form4.xml","form_type":"4"}},{"id":1654017,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See Remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See Remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See Remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See Remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-08T17:09:52.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":63412,"price":13.01,"value":824990.12,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":85939,"source":{"system":"sec-edgar","filing":"0000895345-24-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000035/form4.xml","form_type":"4"}},{"id":1669620,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T16:41:20.000Z","date":"2024-01-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":2.44,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001999371-24-000965","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000199937124000965/ownership.xml","form_type":"4"}},{"id":1669619,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T16:41:20.000Z","date":"2024-01-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.21,"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001999371-24-000965","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000199937124000965/ownership.xml","form_type":"4"}},{"id":1669618,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-01-26T16:41:20.000Z","date":"2024-01-26","kind":"other","planned":false,"acquired":false,"shares":79726,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Merger Agreement entered into by and among the Issuer, Pathos AI, Inc. (\"Parent\") and WK Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), dated as of December 13, 2023 (the \"Merger Agreement\"), pursuant to which Merger Sub completed a tender offer for all of the shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer effective as of January 26, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $1.16 in cash without interest, plus (ii) one contingent value right."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Merger Agreement entered into by and among the Issuer, Pathos AI, Inc. (\"Parent\") and WK Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), dated as of December 13, 2023 (the \"Merger Agreement\"), pursuant to which Merger Sub completed a tender offer for all of the shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer effective as of January 26, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $1.16 in cash without interest, plus (ii) one contingent value right."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Merger Agreement entered into by and among the Issuer, Pathos AI, Inc. (\"Parent\") and WK Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), dated as of December 13, 2023 (the \"Merger Agreement\"), pursuant to which Merger Sub completed a tender offer for all of the shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer effective as of January 26, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $1.16 in cash without interest, plus (ii) one contingent value right."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001999371-24-000965","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000199937124000965/ownership.xml","form_type":"4"}},{"id":1671322,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Warrant (right to purchase)","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1413475,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These Company Warrants do not have an expiration date and are not exercisable to the extent that, following exercise, the holder of such Company Warrant and its affiliates would beneficially own more than 19.99% of the Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by Braslyn Ltd., which is owned by a revocable trust established by Mr. Lewis for the benefit of members of his immediate family. Each reporting person other than Braslyn Ltd. and Mr. Lewis disclaims beneficial ownership of these securities."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2017-11-20","underlying":"Common Stock","underlying_shares":1413475},"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671321,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Warrant (right to purchase)","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3578036,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These Company Warrants do not have an expiration date and are not exercisable to the extent that, following exercise, the holder of such Company Warrant and its affiliates would beneficially own more than 19.99% of the Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by Braslyn Ltd., which is owned by a revocable trust established by Mr. Lewis for the benefit of members of his immediate family. Each reporting person other than Braslyn Ltd. and Mr. Lewis disclaims beneficial ownership of these securities."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":3578036},"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671320,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Warrant (right to purchase)","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":332809,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These Company Warrants do not have an expiration date and are not exercisable to the extent that, following exercise, the holder of such Company Warrant and its affiliates would beneficially own more than 19.99% of the Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. (\"Boxer Management\") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Each of Messrs. Fuglesang, Dissanayake and Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2017-11-20","underlying":"Common Stock","underlying_shares":332809},"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671319,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30518,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These securities are owned directly by Mr. Fuglesang. Each reporting person other than Mr. Fuglesang disclaims beneficial ownership of these securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671318,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3135966,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by Braslyn Ltd., which is owned by a revocable trust established by Mr. Lewis for the benefit of members of his immediate family. Each reporting person other than Braslyn Ltd. and Mr. Lewis disclaims beneficial ownership of these securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671317,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":203754,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are owned directly by Lockend Five, LLC, a limited liability company owned soley by Mr. Dissanayake.  Each reporting person other than Lockend Five, LLC and Mr. Dissanayake disclaims beneficial ownership of these securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671316,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3201440,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. (\"Boxer Management\") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Each of Messrs. Fuglesang, Dissanayake and Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671315,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":287866,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1672970,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-01-23T20:38:03.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a Per Share Exercise Price that was equal to or greater than the Closing Consideration, but was less than the sum of the Closing Consideration and the maximum amount payable in respect of one CVR (the \"Maximum Total Consideration\"), was cancelled and converted into the right to receive a cash payment equal to (A) the excess of (x) the sum of (i) the Closing Consideration plus (ii) the actual Milestone Payment, if any, made in respect of one CVR over (y) the Per Share Exercise Price, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Such payment will be made if, and only if, a Milestone Payment is made in respect of a CVR and will be made at the same time the Milestone Payment is made to holders of CVRs. If the CVR is terminated or expires without payment, no payment will be made with respect to any such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Pursuant to the Merger Agreement, at the Effective Time, each Company Option that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a Per Share Exercise Price that was equal to or greater than the Closing Consideration, but was less than the sum of the Closing Consideration and the maximum amount payable in respect of one CVR (the \"Maximum Total Consideration\"), was cancelled and converted into the right to receive a cash payment equal to (A) the excess of (x) the sum of (i) the Closing Consideration plus (ii) the actual Milestone Payment, if any, made in respect of one CVR over (y) the Per Share Exercise Price, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":64.14,"expiration_date":"2029-01-16","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001140361-24-003538","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1465914/000114036124003538/form4.xml","form_type":"4"}},{"id":1672969,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-01-23T20:38:03.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7520,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each compensatory option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price (\"Per Share Exercise Price\") that was less than the Closing Consideration, was cancelled and converted into the right to receive the sum of (A) a cash payment, without interest, equal to (x) the excess of (1) the Closing Consideration over (2) the Per Share Exercise Price, multiplied by (y) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting) and (B) one CVR for each share of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each compensatory option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price (\"Per Share Exercise Price\") that was less than the Closing Consideration, was cancelled and converted into the right to receive the sum of (A) a cash payment, without interest, equal to (x) the excess of (1) the Closing Consideration over (2) the Per Share Exercise Price, multiplied by (y) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting) and (B) one CVR for each share of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":45.66,"expiration_date":"2033-01-20","underlying":"Common Stock","underlying_shares":7520},"source":{"system":"sec-edgar","filing":"0001140361-24-003538","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1465914/000114036124003538/form4.xml","form_type":"4"}},{"id":1672968,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true}}],"security":"Option to Purchase Common Stock","published_at":"2024-01-23T20:38:03.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each compensatory option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price (\"Per Share Exercise Price\") that was less than the Closing Consideration, was cancelled and converted into the right to receive the sum of (A) a cash payment, without interest, equal to (x) the excess of (1) the Closing Consideration over (2) the Per Share Exercise Price, multiplied by (y) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting) and (B) one CVR for each share of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each compensatory option to purchase shares of Company Common Stock (each, a \"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price (\"Per Share Exercise Price\") that was less than the Closing Consideration, was cancelled and converted into the right to receive the sum of (A) a cash payment, without interest, equal to (x) the excess of (1) the Closing Consideration over (2) the Per Share Exercise Price, multiplied by (y) the total number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting) and (B) one CVR for each share of Company Common Stock subject to such Company Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":39.76,"expiration_date":"2028-12-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001140361-24-003538","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1465914/000114036124003538/form4.xml","form_type":"4"}},{"id":1672967,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-23T20:38:03.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6808,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement and the Company Equity Plans (as such term is defined in the Merger Agreement), at the Effective Time, each of these RSUs that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive a cash award of BMS in an amount equal to the product of the number of restricted stock units subject to such RSU immediately prior to the Effective Time and the last trading price of a share of Company Common Stock before the Effective Time (the \"Converted Cash Award\"). Following the Effective Time, the Converted Cash Award will be subject to the same terms and conditions applicable to such Issuer RSUs, including with respect to vesting."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-24-003538","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1465914/000114036124003538/form4.xml","form_type":"4"}},{"id":1672966,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-23T20:38:03.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4444,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each of these restricted stock units (\"RSUs\") that was outstanding as of immediately prior to the Effective Time was cancelled and the Reporting Person was entitled to receive the Merger Consideration in respect of each such RSU."}],"balance_after":6808,"source":{"system":"sec-edgar","filing":"0001140361-24-003538","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1465914/000114036124003538/form4.xml","form_type":"4"}},{"id":1672965,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-23T20:38:03.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":43073,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 8, 2023, among the Issuer, Bristol-Myers Squibb Company (\"BMS\"), and Vineyard Merger Sub Inc., a wholly owned subsidiary of BMS (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), effective as of January 23, 2024 (such date and time of such Merger, the \"Effective Time\"), with the Issuer surviving the Merger as a wholly owned subsidiary of BMS."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each issued and outstanding share of common stock of the Issuer (\"Company Common Stock\") reported in this Form 4 was converted into the right to receive (A) $58.00 per share in cash (the \"Closing Consideration\") and (B) one contingent value right (a \"CVR\"), which represents the right to receive the Milestone Payment (as such term is defined in the CVR Agreement, which is itself defined in the Merger Agreement) (the consideration contemplated by (A) and (B), together, the \"Merger Consideration\"), without interest and subject to any withholding taxes."}],"balance_after":11252,"source":{"system":"sec-edgar","filing":"0001140361-24-003538","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1465914/000114036124003538/form4.xml","form_type":"4"}},{"id":1692146,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-03T20:50:34.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":6808,"price":58.75,"value":399970.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the anniversary of the grant date."}],"balance_after":54325,"source":{"system":"sec-edgar","filing":"0001628280-24-000357","document":"wk-form4_1704333021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1465914/000162828024000357/wk-form4_1704333021.xml","form_type":"4"}},{"id":1759272,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":5,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-17T19:41:18.000Z","date":"2023-10-16","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":6.84,"value":3420000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.54 to $7.01, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":8198642,"source":{"system":"sec-edgar","filing":"0000895345-23-000589","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000589/form4.xml","form_type":"4/A","original_submission_date":"2023-10-17"}},{"id":1759271,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":5,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-17T19:41:18.000Z","date":"2023-10-13","kind":"purchase","planned":false,"acquired":true,"shares":750000,"price":7.07,"value":5302500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.95 to $7.10, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":7698642,"source":{"system":"sec-edgar","filing":"0000895345-23-000589","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000589/form4.xml","form_type":"4/A","original_submission_date":"2023-10-17"}},{"id":1759270,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":5,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-17T18:04:34.000Z","date":"2023-10-16","kind":"purchase","planned":true,"acquired":true,"shares":500000,"price":6.84,"value":3420000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.54 to $7.01, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":8198642,"source":{"system":"sec-edgar","filing":"0000895345-23-000588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000588/form4.xml","form_type":"4"}},{"id":1759269,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":5,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-17T18:04:34.000Z","date":"2023-10-13","kind":"purchase","planned":true,"acquired":true,"shares":750000,"price":7.07,"value":5302500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.95 to $7.10, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":7698642,"source":{"system":"sec-edgar","filing":"0000895345-23-000588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000588/form4.xml","form_type":"4"}},{"id":1762000,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-11T21:22:57.000Z","date":"2023-10-09","kind":"sale","planned":false,"acquired":false,"shares":175000,"price":9.97,"value":1744750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.6943 to $10.1829, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":6948642,"source":{"system":"sec-edgar","filing":"0000895345-23-000574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000574/form4.xml","form_type":"4"}},{"id":1761999,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-11T21:22:57.000Z","date":"2023-10-09","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":9.91,"value":495500.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 9.6500 to $9.9800, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":693524,"source":{"system":"sec-edgar","filing":"0000895345-23-000574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000574/form4.xml","form_type":"4"}},{"id":1761998,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"other":true,"other_text":"See remarks"}}],"security":"Prefunded Warrant","published_at":"2023-10-11T19:22:22.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":2340579,"price":5.1499,"value":12053747.7921,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":2340579,"derivative":{"underlying":"Common Stock","underlying_shares":2340579},"source":{"system":"sec-edgar","filing":"0000895345-23-000573","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000573/form4.xml","form_type":"4/A","original_submission_date":"2023-08-15"}},{"id":1761997,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":true,"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-10-11T19:22:22.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":475000,"price":5.15,"value":2446250.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":743542,"source":{"system":"sec-edgar","filing":"0000895345-23-000573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000573/form4.xml","form_type":"4/A","original_submission_date":"2023-08-15"}},{"id":1796852,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":4,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-25T21:28:31.000Z","date":"2023-08-23","kind":"sale","planned":false,"acquired":false,"shares":219638,"price":16.87,"value":3705293.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.50 to $17.04, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":1804058,"source":{"system":"sec-edgar","filing":"0000895345-23-000524","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000524/form4.xml","form_type":"4"}},{"id":1796851,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":4,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-25T21:28:31.000Z","date":"2023-08-23","kind":"sale","planned":false,"acquired":false,"shares":95516,"price":15.63,"value":1492915.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.05 to $15.85, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":2023696,"source":{"system":"sec-edgar","filing":"0000895345-23-000524","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000524/form4.xml","form_type":"4"}},{"id":1796850,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":4,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-25T21:28:31.000Z","date":"2023-08-23","kind":"sale","planned":false,"acquired":false,"shares":34846,"price":14.19,"value":494464.74,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.80 to $14.59, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":2119212,"source":{"system":"sec-edgar","filing":"0000895345-23-000524","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000524/form4.xml","form_type":"4"}},{"id":1807689,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-15T21:39:22.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":1201440,"price":27.8,"value":33400032.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. (\"Boxer Management\") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Each of Messrs. Fuglesang, Dissanayake and Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":3201440,"source":{"system":"sec-edgar","filing":"0000895345-23-000500","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000500/form4.xml","form_type":"4"}},{"id":1807688,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-15T21:39:22.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":57533,"price":27.8,"value":1599417.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":287866,"source":{"system":"sec-edgar","filing":"0000895345-23-000500","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000500/form4.xml","form_type":"4"}},{"id":1807687,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-15T21:38:44.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":1201440,"price":27.8,"value":33400032.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. (\"Boxer Management\") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Each of Messrs. Fuglesang, Dissanayake and Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":3201440,"source":{"system":"sec-edgar","filing":"0000895345-23-000499","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000499/form4.xml","form_type":"4"}},{"id":1807686,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-15T21:38:44.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":57533,"price":27.8,"value":1599417.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":287866,"source":{"system":"sec-edgar","filing":"0000895345-23-000499","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000499/form4.xml","form_type":"4"}},{"id":1807685,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Prefunded Warrant","published_at":"2023-08-15T21:34:39.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":2340579,"price":5.1499,"value":12053747.7921,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":2340597,"derivative":{"underlying":"Common Stock","underlying_shares":2340579},"source":{"system":"sec-edgar","filing":"0000895345-23-000498","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000498/form4.xml","form_type":"4"}},{"id":1807684,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2023-08-15T21:34:39.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":475000,"price":5.15,"value":2446250.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":743542,"source":{"system":"sec-edgar","filing":"0000895345-23-000498","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000498/form4.xml","form_type":"4"}},{"id":1809954,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T21:05:55.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 35,000 shares of the Issuer's common stock, which will vest in full on the date of the 2024 Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":35000,"derivative":{"exercise_price":1.21,"expiration_date":"2033-08-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-23-090698","document":"tm2323614-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000110465923090698/tm2323614-3_4seq1.xml","form_type":"4"}},{"id":1854538,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T19:52:33.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":22383,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22383,"derivative":{"exercise_price":14.77,"exercise_date":"2024-06-13","expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":22383},"source":{"system":"sec-edgar","filing":"0001209191-23-037587","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000120919123037587/doc4.xml","form_type":"4"}},{"id":1862570,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T01:32:56.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 6, 2023, subject to the Reporting Person's continuous service  with the Issuer as of each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":3.55,"expiration_date":"2023-06-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-23-015012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924323015012/doc4.xml","form_type":"4"}},{"id":1862569,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T01:32:56.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 6, 2024 and (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-23-015012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924323015012/doc4.xml","form_type":"4"}},{"id":1880253,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks."}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks."}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":4,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-24T20:05:53.000Z","date":"2023-05-22","kind":"sale","planned":false,"acquired":false,"shares":995000,"price":1.25,"value":1243750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.30, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Aaron I. Davis, (iv) MVA Investors, LLC, and (v) Joe Lewis (collectively, the \"Boxer Group\"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein"},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned indirectly by Boxer Management and Joe Lewis, by virtue of their ownership of Boxer Capital."}],"balance_after":1152212,"source":{"system":"sec-edgar","filing":"0000895345-23-000356","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534523000356/form4.xml","form_type":"4"}},{"id":2020225,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"ten_percent_owner":true}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-02-14T02:39:49.000Z","date":"2023-02-10","kind":"sale","acquired":false,"shares":65568,"price":13.4,"value":878611.2,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by MVA Investors, LLC (\"MVA Investors\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) MVA Investors, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) Aaron I. Davis, (v) Joseph C. Lewis and (vi) Siddarth Subramony  (collectively, the \"Boxer Group\"), and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":22527,"source":{"system":"sec-edgar","filing":"0000895345-23-000107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000089534523000107/form4.xml","form_type":"4"}},{"id":2020224,"issuer":{"id":4680,"kind":"organization","name":"Tyra Biosciences, Inc.","symbol":"TYRA"},"owners":[{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":1,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"ten_percent_owner":true}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":2,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"ten_percent_owner":true}}],"security":"Common Stock","published_at":"2023-02-14T02:39:49.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":200000,"price":13.1,"value":2620000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by MVA Investors, LLC (\"MVA Investors\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) MVA Investors, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) Aaron I. Davis, (v) Joseph C. Lewis and (vi) Siddarth Subramony  (collectively, the \"Boxer Group\"), and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":88095,"source":{"system":"sec-edgar","filing":"0000895345-23-000107","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863127/000089534523000107/form4.xml","form_type":"4"}},{"id":2047402,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2023-01-24T16:20:13.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":7520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":7520,"derivative":{"exercise_price":45.66,"expiration_date":"2033-01-20","underlying":"Common Stock","underlying_shares":7520},"source":{"system":"sec-edgar","filing":"0001214659-23-001050","document":"marketforms-58280.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1465914/000121465923001050/marketforms-58280.xml","form_type":"4"}},{"id":2047401,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-01-24T16:20:13.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":4444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs).  Shares will vest 100% on the anniversary of the grant date."}],"balance_after":47517,"source":{"system":"sec-edgar","filing":"0001214659-23-001050","document":"marketforms-58280.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1465914/000121465923001050/marketforms-58280.xml","form_type":"4"}},{"id":2122338,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Voting Common Stock","published_at":"2022-11-08T16:30:24.000Z","date":"2022-11-04","kind":"purchase","acquired":true,"shares":400000,"price":5.83,"value":2332000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Non-Voting Common Stock is convertible into one share of Common Stock at any time at the option of the holder without payment or additional consideration, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, (iv) MVA Investors, LLC and (v) Joe Lewis (collectively, the \"Boxer Group\"). The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":3422489,"derivative":{"underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000899243-22-035366","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924322035366/doc4.xml","form_type":"4"}},{"id":2122337,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-08T16:30:24.000Z","date":"2022-11-04","kind":"purchase","acquired":true,"shares":972212,"price":5.83,"value":5667995.96,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, (iv) MVA Investors, LLC and (v) Joe Lewis (collectively, the \"Boxer Group\"). The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":2147212,"source":{"system":"sec-edgar","filing":"0000899243-22-035366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924322035366/doc4.xml","form_type":"4"}},{"id":2137885,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-13T21:30:12.000Z","date":"2022-10-13","kind":"purchase","acquired":true,"shares":70000,"price":4.6461,"value":325227.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":7123642,"source":{"system":"sec-edgar","filing":"0000899243-22-033595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322033595/doc4.xml","form_type":"4"}},{"id":2137884,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-13T21:30:12.000Z","date":"2022-10-12","kind":"purchase","acquired":true,"shares":50000,"price":4.4328,"value":221640.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC (\"Boxer Capital\"), (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Joseph C. Lewis, (iv) BCTG Holdings, LLC, (v) MVA Investors and (vi) Aaron I. Davis (collectively, the \"Boxer Group\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":268524,"source":{"system":"sec-edgar","filing":"0000899243-22-033595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322033595/doc4.xml","form_type":"4"}},{"id":2137883,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-10-13T21:30:12.000Z","date":"2022-10-11","kind":"purchase","acquired":true,"shares":117000,"price":4.2539,"value":497706.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $4.0500 to $4.2631."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC (\"Boxer Capital\"), (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Joseph C. Lewis, (iv) BCTG Holdings, LLC, (v) MVA Investors and (vi) Aaron I. Davis (collectively, the \"Boxer Group\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":218524,"source":{"system":"sec-edgar","filing":"0000899243-22-033595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322033595/doc4.xml","form_type":"4"}},{"id":2178320,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-19T17:40:57.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's common stock, which will vest in full on June 1, 2023, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20000,"derivative":{"exercise_price":2.44,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-22-029321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924322029321/doc4.xml","form_type":"4"}},{"id":2220317,"issuer":{"id":1497,"kind":"organization","name":"Tango Therapeutics, Inc.","symbol":"TNGX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-28T20:30:04.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year from June 8, 2022, subject to the Reporting Person's continuous service on the board of directors as of each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":5.9,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-22-024402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819133/000089924322024402/doc4.xml","form_type":"4"}},{"id":2236217,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T19:47:29.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":17538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 9, 2023 or (b) the next annual meeting of the Issuer's stockholders."}],"balance_after":17538,"derivative":{"exercise_price":18.78,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":17538},"source":{"system":"sec-edgar","filing":"0001209191-22-036133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000120919122036133/doc4.xml","form_type":"4"}},{"id":2274971,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T21:15:24.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":337109,"price":18.2487,"value":6151801.0083,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the weighted average sale price. Boxer Capital effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. Boxer Capital hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $18.5817 to $17.6656."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":2154058,"source":{"system":"sec-edgar","filing":"0000899243-22-017712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322017712/doc4.xml","form_type":"4"}},{"id":2274970,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T21:15:24.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":891,"price":17.532,"value":15621.012,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price. Boxer Capital effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. Boxer Capital hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $17.59 to $17.5268."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":2491167,"source":{"system":"sec-edgar","filing":"0000899243-22-017712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322017712/doc4.xml","form_type":"4"}},{"id":2274969,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T21:15:24.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":4850,"price":24.7653,"value":120111.705,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. Boxer Capital effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. Boxer Capital hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $24.8245 to $24.7173."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":2492058,"source":{"system":"sec-edgar","filing":"0000899243-22-017712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322017712/doc4.xml","form_type":"4"}},{"id":2274968,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T21:15:24.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":95150,"price":25.1798,"value":2395857.97,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. Boxer Capital effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. Boxer Capital hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $25.8763 to $24.9379."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":2496908,"source":{"system":"sec-edgar","filing":"0000899243-22-017712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322017712/doc4.xml","form_type":"4"}},{"id":2274967,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T21:15:24.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":200000,"price":23.4656,"value":4693120.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. Boxer Capital effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. Boxer Capital hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $24.10 to $23.16430."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":2592058,"source":{"system":"sec-edgar","filing":"0000899243-22-017712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322017712/doc4.xml","form_type":"4"}},{"id":2274966,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T21:15:24.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":25000,"price":22.9089,"value":572722.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":2792058,"source":{"system":"sec-edgar","filing":"0000899243-22-017712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322017712/doc4.xml","form_type":"4"}},{"id":2286577,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-02T21:15:11.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":92700,"price":27.5332,"value":2552327.64,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. Boxer Capital effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. Boxer Capital hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $28.00 to $27.14178."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":2817058,"source":{"system":"sec-edgar","filing":"0000899243-22-016203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322016203/doc4.xml","form_type":"4"}},{"id":2286576,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-02T21:15:11.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":7300,"price":26.905,"value":196406.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":2909758,"source":{"system":"sec-edgar","filing":"0000899243-22-016203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322016203/doc4.xml","form_type":"4"}},{"id":2286575,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-02T21:15:11.000Z","date":"2022-04-29","kind":"sale","acquired":false,"shares":115000,"price":27.0145,"value":3106667.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. Boxer Capital effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. Boxer Capital hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $27.2107 to $26.6900."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":2917058,"source":{"system":"sec-edgar","filing":"0000899243-22-016203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322016203/doc4.xml","form_type":"4"}},{"id":2286574,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-02T21:15:11.000Z","date":"2022-04-29","kind":"sale","acquired":false,"shares":10000,"price":28.2154,"value":282154.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":3032058,"source":{"system":"sec-edgar","filing":"0000899243-22-016203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322016203/doc4.xml","form_type":"4"}},{"id":2286573,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-02T21:15:11.000Z","date":"2022-04-28","kind":"sale","acquired":false,"shares":150000,"price":27.4021,"value":4110315.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. Boxer Capital effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. Boxer Capital hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $27.88464 to $27.16000."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":3042058,"source":{"system":"sec-edgar","filing":"0000899243-22-016203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322016203/doc4.xml","form_type":"4"}},{"id":2318931,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-24T21:00:25.000Z","date":"2022-03-23","kind":"purchase","acquired":true,"shares":20000,"price":32.849,"value":656980.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":3192058,"source":{"system":"sec-edgar","filing":"0000899243-22-012152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322012152/doc4.xml","form_type":"4"}},{"id":2318930,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-24T21:00:25.000Z","date":"2022-03-22","kind":"purchase","acquired":true,"shares":5000,"price":33.4278,"value":167139.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":3172058,"source":{"system":"sec-edgar","filing":"0000899243-22-012152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322012152/doc4.xml","form_type":"4"}},{"id":2318929,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-24T21:00:25.000Z","date":"2022-03-22","kind":"purchase","acquired":true,"shares":3700,"price":33.0898,"value":122432.26,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":3167058,"source":{"system":"sec-edgar","filing":"0000899243-22-012152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322012152/doc4.xml","form_type":"4"}},{"id":2318928,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-24T21:00:25.000Z","date":"2022-03-22","kind":"purchase","acquired":true,"shares":21300,"price":31.875,"value":678937.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). The reporting person may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) the reporting person, and (iv) Joe Lewis. The reporting person disclaims beneficial ownership of these securities to the extent he does not have a pecuniary interest therein."}],"balance_after":3163358,"source":{"system":"sec-edgar","filing":"0000899243-22-012152","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808865/000089924322012152/doc4.xml","form_type":"4"}},{"id":2433670,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2022-01-18T18:17:33.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":3688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant."}],"balance_after":3688,"derivative":{"exercise_price":124.31,"expiration_date":"2032-01-13","underlying":"Common Stock","underlying_shares":3688},"source":{"system":"sec-edgar","filing":"0001214659-22-000842","document":"marketforms-55080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1465914/000121465922000842/marketforms-55080.xml","form_type":"4"}},{"id":2433669,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":86253,"kind":"person","name":"Davis Aaron I.","position":1,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-18T18:17:33.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":2546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs).  Shares will vest 100% on the anniversary of the grant date."}],"balance_after":43073,"source":{"system":"sec-edgar","filing":"0001214659-22-000842","document":"marketforms-55080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1465914/000121465922000842/marketforms-55080.xml","form_type":"4"}},{"id":2445374,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":2517,"price":45.4777,"value":114467.3709,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445373,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":11199,"price":44.4416,"value":497701.4784,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":2517,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445372,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":3138,"price":43.3596,"value":136062.4248,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $42.6291 to $43.4221."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":13716,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445371,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":29623,"price":41.842,"value":1239485.566,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $41.4811 to $42.1440."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":16854,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445370,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":7483,"price":45.4777,"value":340309.6291,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3717259,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445369,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":33297,"price":44.4416,"value":1479771.9552,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3724742,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445368,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":9366,"price":43.36,"value":406109.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $42.6291 to $43.4221."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3758039,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445367,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":88054,"price":41.842,"value":3684355.468,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $41.4811 to $42.1440."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3767405,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445366,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":731,"price":50.6338,"value":37013.3078,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":46477,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445365,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":1682,"price":49.3749,"value":83048.5818,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $49.2035 to $50.1716."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":47208,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445364,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":23353,"price":47.6275,"value":1112245.0075,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $47.4904 to $47.8617."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, which may be deemed to be a member of the Boxer Group for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors and Aaron I. Davis disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein. Following the completion of the transactions reported in this Form 4, MVA Investors no longer holds any securities of the issuer and, therefore, as of January 4, 2022, is no longer a member of the Boxer Group"}],"balance_after":48890,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445363,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":17173,"price":50.6338,"value":869534.2474,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3855459,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445362,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":39481,"price":49.3745,"value":1949354.6345,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $49.2035 to $50.1716."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3872632,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}},{"id":2445361,"issuer":{"id":75965,"kind":"organization","name":"iTeos Therapeutics, Inc.","symbol":"ITOS"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:20:13.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":432903,"price":47.6462,"value":20626182.9186,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $47.4904 to $47.8617."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Aaron I. Davis, and (v) Joseph C. Lewis (collectively, the \"Boxer Group\").  These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3912113,"source":{"system":"sec-edgar","filing":"0000899243-22-001072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924322001072/doc4.xml","form_type":"4"}}],"next_cursor":"2022-01-05T21:20:13.000000Z,2445361"}